These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 11551028

  • 21. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M.
    Cancer; 2002 Nov 01; 95(9):1923-30. PubMed ID: 12404286
    [Abstract] [Full Text] [Related]

  • 22. Veno-occlusive disease in pediatric patients after hematopoietic stem cell transplantation: relevance of activated coagulation and fibrinolysis markers and natural anticoagulants.
    Jevtic D, Zecevic Z, Veljkovic D, Dopsaj V, Radojicic Z, Elezovic I.
    J Pediatr Hematol Oncol; 2011 Apr 01; 33(3):227-34. PubMed ID: 21336167
    [Abstract] [Full Text] [Related]

  • 23. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
    Salat C, Holler E, Göhring P, Poley S, Kolb HJ, Pihusch R, Reinhardt B, Krämling HJ, Haller M, Hiller E.
    Eur J Med Res; 1996 Nov 25; 1(12):571-4. PubMed ID: 9438165
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
    Salat C, Holler E, Wolf C, Kolb HJ, Reinhardt B, Pihusch R, Krämling HJ, Heinemann V, Haller M, Hiller E.
    Bone Marrow Transplant; 1997 Mar 25; 19(5):487-90. PubMed ID: 9052916
    [Abstract] [Full Text] [Related]

  • 27. Increased angiogenic growth factor in cyanotic congenital heart disease.
    Himeno W, Akagi T, Furui J, Maeno Y, Ishii M, Kosai K, Murohara T, Kato H.
    Pediatr Cardiol; 2003 Mar 25; 24(2):127-32. PubMed ID: 12360391
    [Abstract] [Full Text] [Related]

  • 28. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J, Hu J, Cai J.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 25; 23(5):389-92. PubMed ID: 11810769
    [Abstract] [Full Text] [Related]

  • 29. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
    Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T, Hirabayashi N.
    Bone Marrow Transplant; 1998 Dec 25; 22(12):1191-7. PubMed ID: 9894723
    [Abstract] [Full Text] [Related]

  • 30. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia.
    Lee JH, Lee KH, Choi SJ, Min YJ, Kim JG, Kim S, Lee JS, Kim SH, Park CJ, Chi HS, Kim WK.
    Bone Marrow Transplant; 2000 Sep 25; 26(6):657-62. PubMed ID: 11041568
    [Abstract] [Full Text] [Related]

  • 31. [The influence of thyroidectomy of serum VEGF levels in patients with Graves disease].
    Kołomecki K, Bartos M, Pomorski L, Kuzdak K.
    Wiad Lek; 2001 Sep 25; 54(9-10):504-7. PubMed ID: 11816293
    [Abstract] [Full Text] [Related]

  • 32. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
    Zhao J, Hu J, Cai J, Yang X, Yang Z.
    Chin Med J (Engl); 2003 May 25; 116(5):772-6. PubMed ID: 12875699
    [Abstract] [Full Text] [Related]

  • 33. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis.
    Maeno N, Takei S, Imanaka H, Takasaki I, Kitajima I, Maruyama I, Matsuo K, Miyata K.
    J Rheumatol; 1999 Oct 25; 26(10):2244-8. PubMed ID: 10529148
    [Abstract] [Full Text] [Related]

  • 34. Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma.
    Horn B, Reiss U, Matthay K, McMillan A, Cowan M.
    Bone Marrow Transplant; 2002 Mar 25; 29(5):409-15. PubMed ID: 11919731
    [Abstract] [Full Text] [Related]

  • 35. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
    Ferrà C, de Sanjosé S, Gallardo D, Berlanga JJ, Rueda F, Marìn D, de la Banda E, Ancìn I, Peris J, Garcìa J, Grañena A.
    Haematologica; 1998 Dec 25; 83(12):1082-7. PubMed ID: 9949625
    [Abstract] [Full Text] [Related]

  • 36. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy.
    Haussmann U, Fischer J, Eber S, Scherer F, Seger R, Gungor T.
    Haematologica; 2006 Jun 25; 91(6):795-800. PubMed ID: 16769582
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].
    Gozdzik J, Krasowska-Kwiecień A, Wedrychowicz A.
    Przegl Lek; 2008 Jun 25; 65(4):203-8. PubMed ID: 18724548
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study.
    Lee JH, Lee KH, Kim S, Lee JS, Kim WK, Park CJ, Chi HS, Kim SH.
    Bone Marrow Transplant; 1998 Nov 25; 22(9):883-8. PubMed ID: 9827816
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.